Advisornet Financial’s Bio-Rad Laboratories Class A BIO Stock Holding History

Advisornet Financial’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$294	Hold	1	–	–	﹤0.01%	2142
2026 Q1	$279	Sell	1 -2	-67%	-$576	﹤0.01%	2149
2025 Q4	$909	Buy	3 +2	+200%	+$624	﹤0.01%	2008
2025 Q3	$280	Hold	1	–	–	﹤0.01%	2129
2025 Q2	$241	Buy	+1	New	+$236	﹤0.01%	2127
2024 Q4	–	Sell	-6	Closed	-$2.01K	–	1994
2024 Q3	$2.01K	Buy	+6	New	+$1.91K	﹤0.01%	1756
2024 Q2	–	Sell	-5	Closed	-$1.73K	–	2087
2024 Q1	$1.73K	Sell	5 -3	-38%	-$987	﹤0.01%	1623
2023 Q4	$2.58K	Buy	8 +6	+300%	+$1.88K	﹤0.01%	1641
2023 Q3	$717	Sell	2 -1	-33%	-$386	﹤0.01%	1887
2023 Q2	$1.14K	Sell	3 -1	-25%	-$407	﹤0.01%	1850
2023 Q1	$1.92K	Buy	4 +1	+33%	+$468	﹤0.01%	1718
2022 Q4	$1.26K	Buy	3 +2	+200%	+$807	﹤0.01%	1777
2022 Q3	$0	Hold	1	–	–	﹤0.01%	1870
2022 Q2	$0	Buy	+1	New	+$521	﹤0.01%	1884
2018 Q4	–	Sell	-236	Closed	-$74K	–	1469
2018 Q3	$74K	Hold	236	–	–	0.01%	625
2018 Q2	$68K	Hold	236	–	–	0.01%	628
2018 Q1	$59K	Hold	236	–	–	0.01%	653
2017 Q4	$56K	Buy	+236	New	+$57.2K	0.01%	620

Other funds holding BIO

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Advisornet Financial's BIO Position: Q2 2026 in Review

Advisornet Financial held its Bio-Rad Laboratories Class A (BIO) position steady in Q2 2026 at 1 share worth $294. The position accounts for ﹤0.01% of the portfolio, ranked #2142.

Advisornet Financial first reported a position in BIO in Q4 2017 and has held it in 18 quarters since. The position peaked at $74K in Q3 2018. 400 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

Advisornet Financial held 1 share of Bio-Rad Laboratories Class A worth $294 as of Q2 2026.
Advisornet Financial left its Bio-Rad Laboratories Class A share count unchanged in Q2 2026.
Bio-Rad Laboratories Class A made up ﹤0.01% of Advisornet Financial's portfolio in Q2 2026, its #2142 holding.
Advisornet Financial first reported a position in Bio-Rad Laboratories Class A in Q4 2017 and has held it in 18 quarters since.
Advisornet Financial's Bio-Rad Laboratories Class A position peaked at $74K in Q3 2018.
400 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.